3BGL

Hepatoselectivity of Statins: Design and synthesis of 4-sulfamoyl pyrroles as HMG-CoA reductase inhibitors


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.225 Å
  • R-Value Free: 0.251 
  • R-Value Work: 0.208 

wwPDB Validation 3D Report Full Report


This is version 1.2 of the entry. See complete history

Literature

Hepatoselectivity of statins: design and synthesis of 4-sulfamoyl pyrroles as HMG-CoA reductase inhibitors.

Park, W.K.Kennedy, R.M.Larsen, S.D.Miller, S.Roth, B.D.Song, Y.Steinbaugh, B.A.Sun, K.Tait, B.D.Kowala, M.C.Trivedi, B.K.Auerbach, B.Askew, V.Dillon, L.Hanselman, J.C.Lin, Z.Lu, G.H.Robertson, A.Sekerke, C.

(2008) Bioorg.Med.Chem.Lett. 18: 1151-1156

  • DOI: 10.1016/j.bmcl.2007.11.124

  • PubMed Abstract: 
  • 4-Sulfamoyl pyrroles were designed as novel hepatoselective HMG-CoA reductase inhibitors (statins) to reduce myalgia, a statin-induced adverse effect. The compounds were prepared via a [3+2] cycloaddition of a Münchnone with a sulfonamide-substituted ...

    4-Sulfamoyl pyrroles were designed as novel hepatoselective HMG-CoA reductase inhibitors (statins) to reduce myalgia, a statin-induced adverse effect. The compounds were prepared via a [3+2] cycloaddition of a Münchnone with a sulfonamide-substituted alkyne. We identified compounds with greater selectivity for hepatocytes compared to L6-myocytes than rosuvastatin and atorvastatin. There was an inverse correlation of myocyte potencies and ClogP values. A number of analogs were effective at reducing cholesterol in acute and chronic in vivo models but they lacked sufficient chronic in vivo activity to warrant further development.


    Organizational Affiliation

    Department of Chemistry, CVMED, Pfizer Global Research and Development, Michigan Laboratories, Ann Arbor, MI, USA. wkcpark@gmail.com




Macromolecules

Find similar proteins by: Sequence  |  Structure

Entity ID: 1
MoleculeChainsSequence LengthOrganismDetails
3-hydroxy-3-methylglutaryl-coenzyme A reductase
A, B, C, D
441Homo sapiensMutation(s): 1 
Gene Names: HMGCR
EC: 1.1.1.34
Find proteins for P04035 (Homo sapiens)
Go to Gene View: HMGCR
Go to UniProtKB:  P04035
Small Molecules
Ligands 1 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
RID
Query on RID

Download SDF File 
Download CCD File 
A, B, C, D
(3R,5R)-7-[2-(4-fluorophenyl)-5-(1-methylethyl)-4-(morpholin-4-ylsulfonyl)-3-phenyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid
C30 H37 F N2 O7 S
XLVZRBHNHHAPDT-JWQCQUIFSA-N
 Ligand Interaction
External Ligand Annotations 
IDBinding Affinity (Sequence Identity %)
RIDIC50: 4.5 nM BINDINGMOAD
RIDIC50: 4.5 nM PDBBIND
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.225 Å
  • R-Value Free: 0.251 
  • R-Value Work: 0.208 
  • Space Group: P 1 21 1
Unit Cell:
Length (Å)Angle (°)
a = 71.588α = 90.00
b = 172.156β = 117.24
c = 75.148γ = 90.00
Software Package:
Software NamePurpose
REFMACrefinement
HKL-2000data scaling
DENZOdata reduction
PDB_EXTRACTdata extraction
SCALEPACKdata scaling
HKL-2000data reduction

Structure Validation

View Full Validation Report or Ramachandran Plots



Entry History 

Deposition Data

Revision History 

  • Version 1.0: 2008-01-29
    Type: Initial release
  • Version 1.1: 2011-07-13
    Type: Version format compliance
  • Version 1.2: 2017-10-25
    Type: Refinement description